Ziprasidone Tablet Franchise in Ahmedabad

Antipsychotic Tablet Supplier in Mumbai

CNS Medicine Distributor in Delhi

Psychiatric Care Pharma Franchise in Bangalore

Ziprasidone Tablet Stockist in Hyderabad
CNS Tablet Manufacturer & Exporter in Chandigarh

Home/Products /ziprasidone-20mg-tablet

Zipradine 20 Tablet

Composition : Ziprasidone (20mg) Tablet

Dosage Form : Tablet

Packaging Type : Alu strip

Packaging : 10*10

Price : ₹0/-

Zipradine 20 Tablet contains Ziprasidone 20mg, an atypical antipsychotic used in the management of schizophrenia, bipolar disorder, and related psychiatric conditions. It helps in controlling symptoms such as hallucinations, delusions, and mood swings.

Ziprasidone works by modulating dopamine and serotonin receptors in the brain, restoring chemical balance and improving mood, behavior, and thought processes in patients with psychiatric disorders.

This tablet is commonly used in long-term management and maintenance therapy, helping patients achieve better stability and reducing the risk of relapse when taken under medical supervision.

Zipradine 20 Tablet is valued for its effective symptom control, predictable pharmacological profile, and consistent clinical performance. Its role in psychiatric therapy makes it an essential choice for hospitals, mental health clinics, and CNS-focused treatment programs.

Read More

About the Product

Zipradine 20 Tablet contains Ziprasidone 20mg, an atypical antipsychotic used in the management of schizophrenia, bipolar disorder, and related psychiatric conditions. It helps in controlling symptoms such as hallucinations, delusions, and mood swings.

Ziprasidone works by modulating dopamine and serotonin receptors in the brain, restoring chemical balance and improving mood, behavior, and thought processes in patients with psychiatric disorders.

This tablet is commonly used in long-term management and maintenance therapy, helping patients achieve better stability and reducing the risk of relapse when taken under medical supervision.

Zipradine 20 Tablet is valued for its effective symptom control, predictable pharmacological profile, and consistent clinical performance. Its role in psychiatric therapy makes it an essential choice for hospitals, mental health clinics, and CNS-focused treatment programs.

Common side effects may include dizziness, drowsiness, nausea, vomiting, headache, and restlessness. Rare but serious side effects include tardive dyskinesia, neuroleptic malignant syndrome, QT prolongation, and metabolic changes such as weight gain or elevated blood sugar. Patients should report any severe or persistent symptoms to their doctor.

Zipradine 20 Tablet is indicated for the treatment of schizophrenia, bipolar disorder (acute manic or mixed episodes), and other psychotic disorders as prescribed by a psychiatrist. It helps control agitation, mood swings, and psychotic episodes.

Zipradine 20 Tablet should be taken strictly as prescribed, usually with food to improve absorption. Avoid alcohol and be cautious when performing tasks requiring alertness. Regular medical monitoring, including heart and metabolic evaluations, is recommended during prolonged therapy.

Zipradine 20 Tablet should be taken strictly as prescribed, usually with food to improve absorption. Avoid alcohol and be cautious when performing tasks requiring alertness. Regular medical monitoring, including heart and metabolic evaluations, is recommended during prolonged therapy.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation